This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

RAN-Zopiclone (2015-09-25)

Starting date:
September 25, 2015
Posting date:
October 6, 2015
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-55150

Affected Products

RAN-Zopiclone

Reason

Lot may contain oversized tablets exceeding the maximum recommended daily dose of 7.5 mg

Depth of distribution

Wholesalers

Affected products

RAN-Zopiclone

DIN, NPN, DIN-HIM
DIN 02267926
Dosage form

Tablet

Strength

Zopiclone 7.5 mg

Lot or serial number

487796

Companies
Recalling Firm
Ranbaxy Pharmaceuticals Canada Inc.
200-2680 Matheson Blvd. East
Mississauga
L4W 0A5
Ontario
CANADA
Marketing Authorization Holder
Ranbaxy Pharmaceuticals Canada Inc.
200-2680 Matheson Blvd. East
Mississauga
L4W 0A5
Ontario
CANADA

Date modified: